Jesse Jung, MD
Ophthalmology · Oakland, CANPI 1033351689
Payments from drug & device makers
Across 143 payments — averaging $537.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$45K
- Chugai Pharmaceutical Co., Ltd.$13K
- AbbVie$8K
- Regeneron$4K
- Topcon Healthcare, Inc.$3K
- Genentech, Inc.$2K
- plus $3K from 14 others
Across 4 payments — averaging $1240.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$5K
What the payments were for
- Consulting fees$28,30141%
- Speaking & faculty fees$22,41033%
- Travel & lodging$11,08916%
- Food & beverage$4,0676%
- Education$2,5004%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 39 | $44,979 |
| Chugai Pharmaceutical Co., Ltd. | 4 | $12,732 |
| AbbVie | 17 | $7,663 |
| Regeneron | 13 | $3,720 |
| Topcon Healthcare, Inc. | 1 | $2,500 |
| Genentech, Inc. | 7 | $2,067 |
| Alimera Sciences, Inc. | 8 | $1,476 |
| Genentech USA, Inc. | 28 | $958 |
| Astellas Pharma US Inc | 15 | $405 |
| Heidelberg Engineering, Inc. | 1 | $88 |
| Alcon | 1 | $61 |
| Astellas Pharma Global Development | 1 | $51 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| Amgen | 1 | $27 |
| Apellis Pharmaceuticals, Inc. | 1 | $27 |
| Oyster Point Pharma, Inc. | 1 | $27 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $19 |
| Eyepoint US, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CIRRUS HD-OCT$19,605
- FORUM$10,000
- VisuMax$9,375
- OPMI Lumera 700$7,380
- OZURDEX$7,289
- Clarus 700$4,950
- Cataract Suite$3,530
- EYLEA HD$3,290
- CIRRUS 6000 with AngioPlex$2,975
- Humphrey Field Analyzer (HFA3)$2,975
- OCT MAESTRO$2,500
- PLEX Elite$2,434
- CLARUS$2,165
- Lucentis$1,760
- QUATERA 700$1,540
- CALLISTO eye$1,540
- Iluvien$1,248
- IOLMaster 700$1,136
- FORUM Glaucoma Workplace$665
- Retina Workplace$665
How this compares
$76,906 in reported general payments places this provider in the 90th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 71 | $3,851 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 55 | $886 |
| Ketorolac Tromethamine | 43 | $734 |
| Latanoprost | 43 | $703 |
| Brimonidine Tartrate | 16 | $425 |
| Atropine Sulfate | 11 | $334 |
| Dorzolamide Hcl | 18 | $222 |
| Timolol Maleate | 13 | $167 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $137 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Oakland
- Soraya RofaghaOakland$2M
- Nisha AcharyaSan Francisco$33M
- David WirtaNewport Beach$18.4M
- Michael IpPasadena$10.2M
- Raymond DouglasBeverly Hills$9.7M
- Sherif El HaraziGlendale$9.2M
- Daniel SchwartzSan Francisco$8M
- Nikolas Londonla Jolla$6.1M
- Michael BerlinWest Hollywood$5.7M
- Steven JacobsonLos Angeles$4.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.